Why the study?
Initiation of antiarrhythmic drug therapy for atrial fibrillation on an outpatient basis requires intensive ECG monitoring to evaluate efficacy and potential proarrhythmia signals.
Does dronedarone with transtelephonic ECG monitoring safely prevent AF recurrence in patients with symptomatic non-permanent AF?
Observational (n=19)
No
Does dronedarone with transtelephonic ECG monitoring safely prevent AF recurrence in patients with symptomatic non-permanent AF?
Answers are grounded in this paper and cite their sources.
Transtelephonic ECG monitoring is a safe and feasible method for guiding the outpatient initiation of dronedarone in patients with non-permanent AF, though long-term efficacy of dronedarone alone was modest (26%).
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
A 2019 study conducted an observational in Non-permanent atrial fibrillation (n=19). Transtelephonic ECG monitoring to guide antiarrhythmic drug therapy was evaluated on Prevention of atrial fibrillation recurrence with dronedarone alone at long-term follow-up.
Synapse has enriched 10 related papers. Consider them for comparative context: